DelveInsight’s “Psoriatic Arthritis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Psoriatic Arthritis Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Psoriatic Arthritis market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Psoriatic Arthritis: An Overview
Psoriatic arthritis (PsA) is a heterogeneous chronic inflammatory rheumatic disease characterized by pain, stiffness, swollen joints, joint erosion, and bone formation. Clinical manifestations vary greatly between patients. It can present with oligoarticular joint involvement that is typically asymmetric or as a polyarticular disease affecting five or more joints, usually with an asymmetric distribution similar to that of rheumatoid arthritis.
The current practice relies on the individualizing choice of treatment by matching the most severely affected domains of the patients with the best available evidence of the efficacies of drugs for those domains. When patients do not respond to treatment, shifting and cycling through different options would be the rational steps.
Psoriatic Arthritis Market Key Facts
-
According to the study by Pérez et. al (2020), the prevalence of PsA in Spain was among the highest reported to date, only below that reported in Norway (0.67%) and slightly higher than that reported in Italy (0.42%).
-
According to the National Psoriatic Foundation, about 1 in 3 people or 30% with psoriasis develop psoriatic arthritis (PsA) – as many as 2.4 million Americans – and PsA can develop at any age.
-
According to a retrospective study of German healthcare insurance data, PsA had prevalence rate of 0.3% respectively, in 2016 (Grellmann et al., 2020)
-
As per the estimates by DelveInsight, there is no gender-based difference, but the prevalence of severe cases is the highest, followed by moderate and mild.
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Psoriatic Arthritis market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.
The report gives complete detail of the Psoriatic Arthritis market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.
Psoriatic Arthritis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders.
Psoriatic Arthritis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Psoriatic Arthritis market or expected to get launched during the study period. The analysis covers Psoriatic Arthritis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Psoriatic Arthritis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Learn How Psoriatic Arthritis Market Will Evolve by 2032 @ https://www.delveinsight.com/sample-request/psoriatic-arthritis-market
Some of the key companies in the Psoriatic Arthritis Market include:
-
Pfizer
-
AbbVie
-
Sun Pharma
-
UCB Biopharma
-
Bristol-Myers Squibb
And many others.
Psoriatic Arthritis therapies covered in the report include:
-
Skyrizi
-
Ilumya (tildrakizumab-asmn)
-
Deucravacitinib
-
Rinvoq
-
Bimekizumab
-
Brepocitinib
And many more.
Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More:
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Psoriatic Arthritis Competitive Intelligence Analysis
4. Psoriatic Arthritis Market Overview at a Glance
5. Psoriatic Arthritis Disease Background and Overview
6. Psoriatic Arthritis Patient Journey
7. Psoriatic Arthritis Epidemiology and Patient Population (In US, EU5, and Japan)
8. Psoriatic Arthritis Treatment Algorithm, Current Treatment, and Medical Practices
9. Psoriatic Arthritis Unmet Needs
10. Key Endpoints of Psoriatic Arthritis Treatment
11. Psoriatic Arthritis Marketed Products
12. Psoriatic Arthritis Emerging Drugs and Latest Therapeutic Advances
13. Psoriatic Arthritis Seven Major Market Analysis
14. Attribute Analysis
15. Psoriatic Arthritis Market Outlook (In US, EU5, and Japan)
16. Psoriatic Arthritis Access and Reimbursement Overview
17. KOL Views on the Psoriatic Arthritis Market
18. Psoriatic Arthritis Market Drivers
19. Psoriatic Arthritis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF to Explore the Key Offerings of the Report:
https://www.delveinsight.com/sample-request/psoriatic-arthritis-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Other Trending Healthcare Reports By DelveInsight
Carpal Tunnel Release System Market
“Carpal Tunnel Release System Market” research report provides comprehensive insights into the historic and forecasted market size, share, trends, and growth estimation for the Carpal Tunnel Release System. It also covers the latest breakthroughs, collaboration, latest innovations, emerging devices, and key companies working in the global Carpal Tunnel Release System market.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/